A new law in Washington that requires pharmaceutical sales representatives to obtain a special license to sell pharmaceutical products in the District will not affect representatives attending medical meetings or conventions in D.C. The SafeRX law, which went into effect April 1, created concern for medical meeting planners who thought that the legislation might have an impact their meetings. Initially, the law was not clear on how it would affect pharmaceutical sales representatives, also ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the New D.C. Law Won’t Affect Medical Meetings, you'll also gain access to exclusive premium content.

Already registered? here.